NVG, LLC for BIOGEN
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Termination (this page) | Jan 20, 2015 | $50,000 | Replaced |
| 4th Quarter - Termination Amendment | Jan 20, 2015 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Newborn Screening Saves Lives Reauthorizations (S. 1417, HR 1281)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER New | — |
| ANDREA LARUE New | — |
Copyright/Patent/Trademark CPT
Patent Quality Improvement Act of 2013 (S. 866, H.R. 2766), Patent Abuse Reduction Act of 2013 (S. 1013, H.R. 2639); The Innovation Act (HR 3309); Patent Transparency and Improvements Act of 2013 (S. 1720); General issues related to intellectual property and potential changes to the patent system
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.